Compare FDS & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDS | RVTY |
|---|---|---|
| Founded | 1978 | 1937 |
| Country | United States | United States |
| Employees | 6258 | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 11.8B |
| IPO Year | 1996 | 1994 |
| Metric | FDS | RVTY |
|---|---|---|
| Price | $210.95 | $87.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 15 |
| Target Price | ★ $292.40 | $113.00 |
| AVG Volume (30 Days) | 843.6K | ★ 1.0M |
| Earning Date | 03-31-2026 | 04-27-2026 |
| Dividend Yield | ★ 2.10% | 0.33% |
| EPS Growth | ★ 11.79 | N/A |
| EPS | ★ 4.06 | 2.07 |
| Revenue | $1,435,351,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $6.51 | $6.34 |
| Revenue Next Year | $5.26 | $5.10 |
| P/E Ratio | $51.52 | ★ $41.40 |
| Revenue Growth | ★ 6.31 | N/A |
| 52 Week Low | $185.00 | $81.36 |
| 52 Week High | $473.33 | $118.30 |
| Indicator | FDS | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 45.20 | 39.54 |
| Support Level | $201.67 | $83.11 |
| Resistance Level | $230.03 | $88.60 |
| Average True Range (ATR) | 7.07 | 2.81 |
| MACD | 1.34 | -0.10 |
| Stochastic Oscillator | 32.86 | 28.26 |
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for over 80% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.